xolair - search results
If you're not happy with the results, please do another search
Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis
Small study finds drug may be effective in treating IA.
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3 Trial
Assessment for both single agent and add-on therapy.
United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple Foods
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
OIT is a Therapy, Not an Ideology
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.
Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating Food Allergies
Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour of food...
Must See: 'ViewFinder: Food for Thought – Food Allergies'
This documentary should be required viewing for everyone as the food allergy epidemic has affected so many in the community.
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food Allergies
Patients reached full tolerance for 70.4% of the tested foods which were reintroduced to the patients’ diet without the need for OIT.
Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection from Allergies in...
"We discovered that preventing infant mice from creating antibodies would effectively diminish the risk of allergies in their adult lives."
